Lisa Seidel

12PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 11, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot, Lisa Paschold, Eray Goekkurt

|Aug 21, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors.

Christoph Schultheiß, Lisa Paschold, Alma Nazlie Mohebiany

|Jul 31, 2024
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection.

Christoph Schultheiß, Edith Willscher, Lisa Paschold

|Feb 02, 2024
Mutation-specific CAR T cells as precision therapy for IGLV3-21<sup>R110</sup> expressing high-risk chronic lymphocytic leukemia.

Florian Märkl, Christoph Schultheiß, Murtaza Ali

|Jun 16, 2023
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial.

Lisa Paschold, Alexander Stein, Benjamin Thiele

|Apr 27, 2023
Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis.

Christoph Schultheiß, Silja Steinmann, Edith Willscher

Pageof 2

Frequent Collaborators

11 joint publications

Mascha Binder

9 joint publications

Christoph Schultheiß

5 joint publications

Edith Willscher

2 joint publications

Rebekka Scholz